92 related articles for article (PubMed ID: 27328865)
1. Metacycloprodigiosin induced cell death selectively in β-catenin-mutated tumor cells.
Ikeda H; Shikata Y; Watanapokasin R; Tashiro E; Imoto M
J Antibiot (Tokyo); 2017 Jan; 70(1):109-112. PubMed ID: 27328865
[No Abstract] [Full Text] [Related]
2. Prodigiosin 25-C and metacycloprodigiosin suppress the bone resorption by osteoclasts.
Woo JT; Ohba Y; Tagami K; Sumitani K; Kataoka T; Nagai K
Biosci Biotechnol Biochem; 1997 Feb; 61(2):400-2. PubMed ID: 9058987
[TBL] [Abstract][Full Text] [Related]
3. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.
Wang Z; Li B; Zhou L; Yu S; Su Z; Song J; Sun Q; Sha O; Wang X; Jiang W; Willert K; Wei L; Carson DA; Lu D
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13150-13155. PubMed ID: 27799526
[TBL] [Abstract][Full Text] [Related]
4. Potent in vitro anticancer activity of metacycloprodigiosin and undecylprodigiosin from a sponge-derived actinomycete Saccharopolyspora sp. nov.
Liu R; Cui CB; Duan L; Gu QQ; Zhu WM
Arch Pharm Res; 2005 Dec; 28(12):1341-4. PubMed ID: 16392666
[TBL] [Abstract][Full Text] [Related]
5. Effects of prodigiosin 25-C on cultured cell lines: its similarity to monovalent polyether ionophores and vacuolar type H(+)-ATPase inhibitors.
Kataoka T; Magae J; Kasamo K; Yamanishi H; Endo A; Yamasaki M; Nagai K
J Antibiot (Tokyo); 1992 Oct; 45(10):1618-25. PubMed ID: 1473989
[TBL] [Abstract][Full Text] [Related]
6. Prodigiosin 25-C suppression of cytotoxic T cells in vitro and in vivo similar to that of concanamycin B, a specific inhibitor of vacuolar type H(+)-ATPase.
Lee MH; Kataoka T; Magae J; Nagai K
Biosci Biotechnol Biochem; 1995 Aug; 59(8):1417-21. PubMed ID: 7549091
[TBL] [Abstract][Full Text] [Related]
7. A novel N-alkylated prodigiosin analogue induced death in tumour cell through apoptosis or necrosis depending upon the cell type.
Deorukhkar AA; Chander R; Pandey R; Sainis KB
Cancer Chemother Pharmacol; 2008 Mar; 61(3):355-63. PubMed ID: 17429627
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products.
Manderville RA
Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):195-218. PubMed ID: 12678767
[TBL] [Abstract][Full Text] [Related]
9. ZT-25, a new vacuolar H(+)-ATPase inhibitor, induces apoptosis and protective autophagy through ROS generation in HepG2 cells.
Lu Y; Zhang R; Liu S; Zhao Y; Gao J; Zhu L
Eur J Pharmacol; 2016 Jan; 771():130-8. PubMed ID: 26689625
[TBL] [Abstract][Full Text] [Related]
10. Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho‑LRP6 expression in Wnt/β-catenin signaling.
Shen W; Zou X; Chen M; Shen Y; Huang S; Guo H; Zhang L; Liu P
Oncol Rep; 2013 Aug; 30(2):851-5. PubMed ID: 23754096
[TBL] [Abstract][Full Text] [Related]
11. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC
Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282
[TBL] [Abstract][Full Text] [Related]
12. The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathway.
Soto-Cerrato V; Viñals F; Lambert JR; Pérez-Tomás R
Biochem Pharmacol; 2007 Nov; 74(9):1340-9. PubMed ID: 17765876
[TBL] [Abstract][Full Text] [Related]
13. Identification of a prodigiosin cyclization gene in the roseophilin producer and production of a new cyclized prodigiosin in a heterologous host.
Kimata S; Izawa M; Kawasaki T; Hayakawa Y
J Antibiot (Tokyo); 2017 Feb; 70(2):196-199. PubMed ID: 27460763
[No Abstract] [Full Text] [Related]
14. Inhibition of vacuolar H+ ATPase enhances sensitivity to tamoxifen via up-regulation of CHOP in breast cancer cells.
Jin HO; Lee YH; Kim HA; Kim EK; Noh WC; Kim YS; Hwang CS; Kim JI; Chang YH; Hong SI; Hong YJ; Park IC; Lee JK
Biochem Biophys Res Commun; 2013 Aug; 437(3):463-8. PubMed ID: 23838288
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic prodigiosin family pigments from Pseudoalteromonas sp. 1020R isolated from the Pacific coast of Japan.
Wang Y; Nakajima A; Hosokawa K; Soliev AB; Osaka I; Arakawa R; Enomoto K
Biosci Biotechnol Biochem; 2012; 76(6):1229-32. PubMed ID: 22790952
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-cancer activity of C-ring-functionalized prodigiosin analogues.
Regourd J; Ali AA; Thompson A
J Med Chem; 2007 Apr; 50(7):1528-36. PubMed ID: 17348639
[TBL] [Abstract][Full Text] [Related]
17. Biological effects of a new vacuolar-H,-ATPase inhibitor in colon carcinoma cell lines.
Supino R; Scovassi AI; Croce AC; Dal Bo L; Favini E; Corbelli A; Farina C; Misiano P; Zunino F
Ann N Y Acad Sci; 2009 Aug; 1171():606-16. PubMed ID: 19723111
[TBL] [Abstract][Full Text] [Related]
18. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
[TBL] [Abstract][Full Text] [Related]
19. Prodigiosin induces cell death and morphological changes indicative of apoptosis in gastric cancer cell line HGT-1.
Díaz-Ruiz C; Montaner B; Pérez-Tomás R
Histol Histopathol; 2001 Apr; 16(2):415-21. PubMed ID: 11332697
[TBL] [Abstract][Full Text] [Related]
20. Development of a merged conjugate addition/oxidative coupling sequence. Application to the enantioselective total synthesis of metacycloprodigiosin and prodigiosin R1.
Clift MD; Thomson RJ
J Am Chem Soc; 2009 Oct; 131(40):14579-83. PubMed ID: 19754115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
